Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.

Last updated on 3-1-2024 by Marie Malingreau

Public Access


Peer reviewed scientific article



The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that assays detecting high-risk human papillomavirus (hrHPV) deoxyribonucleic acid (DNA) are more effective than cytology-based screening. Validation of new hrHPV DNA assays requires both noninferior clinical accuracy compared to a standard comparator for cervical precancer and good reproducibility. This study builds upon previous diagnostic accuracy assessments of the RIATOL HPV genotyping qPCR assay and aims to evaluate the international validatio…

Associated health topics:

QR code

QR code for this page URL